Pharmaceutical reversal of insulin resistance

被引:0
|
作者
Lautt, WW [1 ]
Macedo, MP [1 ]
Sadri, P [1 ]
Legare, DJ [1 ]
Reid, MAG [1 ]
Guarino, MP [1 ]
机构
[1] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Insulin action is approximately doubled following a meal. The mechanism of postprandial insulin sensitization is dependent on hepatic parasympathetic nerves regulated by the prandial status. The nerves provide a permissive signal to the liver that allows insulin to cause the release of a putative hepatic insulin sensitizing substance (HISS) that selectively stimulates glucose uptake into skeletal muscle but not liver or adipose tissue. The parasympathetic signal has several steps identified in the regulatory pathway; acetylcholine acts on muscarinic receptors leading to activation of nitric oxide synthase and generation of HISS. The meal-induced insulin (MIS) sensitization requires hepatic GSH, which decreases with fasting and several disease states. Interfering with the MIS process results in severe insulin resistance with the response to insulin being reduced by approximately 50% to levels seen in the fasted state. A wide range of conditions have been shown to be associated with insulin resistance attributed to lack of the MIS process including insulin resistance; in chronic liver disease produced by chemical damage or bile duct ligation, hepatic denervation, sucrose fed rats, aging, spontaneously hypertensive rats, fetal alcohol exposed adult offspring, spontaneously insulin resistant rats, animals with pharmacological blockade of hepatic muscarinic receptors, NO synthase, cyclooxygenase, hepatic cGMP, and hepatic GSH levels. Pharmaceutical reversal of insulin resistance has been shown in several models using a variety of approaches including mimicking or potentiating the parasympathetic signal using cholinergic agonists, NO donors, cholinesterase antagonists, phosphodiesterase antagonists, and replenishment of hepatic GSH levels. These compounds are being evaluated for therapeutic application by our international academic/industry collaborative team. The MIS process has now been demonstrated in mice, rats, guinea pigs, cats, dogs, and humans, and has been demonstrated by independent laboratories.
引用
收藏
页码:30 / 32
页数:3
相关论文
共 50 条
  • [1] Reversal of insulin resistance in the streptozotocin model of insulin dependent diabetes mellitus
    Nordquist, L
    Sjöquist, M
    FASEB JOURNAL, 2005, 19 (04): : A241 - A241
  • [2] REVERSAL OF INSULIN RESISTANCE BY ATP IN HEMORRHAGIC-SHOCK
    CHAUDRY, IH
    SAYEED, MM
    BAUE, AE
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1975, 53 (05) : 859 - 865
  • [3] Reversal of hexosamine-induced insulin resistance by troglitazone
    Mcclain, D
    Cooksey, RC
    DIABETES, 1998, 47 : A243 - A243
  • [4] REVERSAL OF INSULIN RESISTANCE IN RED CELL GLUCOSE TRANSPORT
    RIESER, P
    FEDERATION PROCEEDINGS, 1963, 22 (02) : 443 - &
  • [5] REVERSAL OF INSULIN RESISTANCE IN RED CELL SUGAR TRANSPORT
    RIESER, P
    RIESER, CH
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1964, 105 (01) : 20 - &
  • [6] Linking the reversal of gestational insulin resistance to postpartum depression
    Abeysekera, Minoli Vinoda
    Ni, Duan
    Gilbert, Leah
    Hibbert, Emily
    Nanan, Ralph
    BMC MEDICINE, 2024, 22 (01):
  • [7] Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling
    Kirwan, JP
    Varastehpour, A
    Jing, M
    Presley, L
    Shao, JH
    Friedman, JE
    Catalano, PM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4678 - 4684
  • [8] Reversal of insulin resistance by in vivo IL-6 neutralization
    Cai, DS
    Yuan, MS
    Clermont, A
    Lee, JS
    Shoelson, SE
    DIABETES, 2005, 54 : A367 - A368
  • [9] Myocardial insulin resistance in aging rats and its reversal by exercise
    Li, Q. X.
    Zhang, Q. J.
    Zhang, H. F.
    Zhang, K. R.
    Gao, F.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S57 - S57
  • [10] Reversal of hexosamine-induced insulin resistance by troglitazone.
    McClain, DA
    Cooksey, RC
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 32A - 32A